fashion -WSS

fashion

author：leisure time 2025-10-02 21:06:06 - browse：9618

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： FDA warns medical device makers about rise in fabricated data

hotspot

WSS

Indictment alleges Trump's ex

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Measles policy set amid Florida outbreak alarms vaccine proponents

Medicare Advantage enrollment hits roughly 33.4 million

As AI regulations shape up, health tech startups beg for clarity

New study raises questions about niacin and heart health

focus

fashion

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Schizophrenia gene found to be linked to cells' energy dysfunction

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

State Dept. review finds Biden bears some blame for Afghanistan failures

Bird flu researchers hone in on Finland’s mink farms

Medicare proposal to cover medical devices draws a mixed reaction

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Medical records are filled with copy

MD Anderson's Padmanee Sharma responds to research credit suit

entertainment

Timeline: How the deadly wildfires took over Maui day by day

Patients, digital health players weigh in on FTC's data privacy plan

Measles policy set amid Florida outbreak alarms vaccine proponents

WATCH: Why do our ears pop?

Secretariat’s lessons for human medicine

Treatments for cramps don't cut it. Why aren't there better options?

explore

hotspot

hotspot

hotspot